Caricamento...
2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control
Current anti-seizure drugs (ASDs) are believed to reduce neuronal excitability through modulation of ion channels and transporters that regulate excitability at the synaptic level. While most patients with epilepsy respond to ASDs, many remain refractory to medical treatment but respond favorably to...
Salvato in:
| Pubblicato in: | Front Cell Neurosci |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503754/ https://ncbi.nlm.nih.gov/pubmed/31114484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2019.00172 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|